memantine has been researched along with amantadine in 129 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 43 (33.33) | 18.7374 |
1990's | 30 (23.26) | 18.2507 |
2000's | 24 (18.60) | 29.6817 |
2010's | 21 (16.28) | 24.3611 |
2020's | 11 (8.53) | 2.80 |
Authors | Studies |
---|---|
Gianutsos, G; Hane, JT; Henkel, JG | 1 |
Hecht, P; Kornhuber, J; Koutsilieri, E; Kroemer, RT; Liedl, KR; Riederer, P | 1 |
Akhoundova, A; Arndt, P; Baumann, C; Busch, AE; Gorboulev, V; Karbach, U; Koepsell, H; Lang, F; Miska, D; Sonders, MS; Ulzheimer, JC; Volk, C; Waldegger, S | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Camins, A; Camps, P; Cortés, D; De Clercq, E; Duque, MD; Ivorra, D; Kelly, JM; López-Querol, M; Naesens, L; Pallàs, M; Prathalingam, SR; Romero, V; Sureda, FX; Vázquez, S | 1 |
Camps, P; De Clercq, E; Duque, MD; Kelly, JM; López-Querol, M; Mallol, J; Montaner, S; Naesens, L; Prathalingam, SR; Profire, L; Sureda, FX; Vázquez, S | 1 |
Camins, A; Camps, P; Duque, MD; Kelly, JM; López-Querol, M; Prathalingam, SR; Sureda, FX; Torres, E; Valverde, E; Vázquez, S | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Duque, MD; Kelly, JM; López-Querol, M; Ma, C; Naesens, L; Pinto, LH; Sureda, FX; Taylor, MC; Torres, E; Vázquez, S | 1 |
Chen, W; Hanaoka, K; Ichinose, F; Liu, J; Marutani, E; Nagano, T; Sakaguchi, M; Sasakura, K; Xian, M | 1 |
Daniliuc, C; Ehrhardt, C; Frehland, B; Lehmkuhl, K; Schepmann, D; Torres-Gómez, H; Wünsch, B | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Barbier, J; Cintrat, JC; Davey, RA; Gillet, D; Kali, S; Noël, R; Pons, V; Popoff, MR; Shtanko, O; Tordo, N; Wu, Y | 1 |
Egunlusi, AO; Ekpo, OE; Joubert, J; Malan, SF; Omoruyi, SI; Palchykov, VA | 1 |
Brea, JM; Companys-Alemany, J; Griñán-Ferré, C; Johnson, JW; Kurnikova, MG; Loza, MI; Pallàs, M; Patel, DS; Pérez, B; Phillips, MB; Soto, D; Sureda, FX; Turcu, AL; Vázquez, S | 1 |
Fischer, PA; Jacobi, P; Schneider, E; Schönberger, B | 1 |
Clark, WG; Menon, MK | 2 |
Schollmeyer, JD; Sturm, G; Wesemann, W | 2 |
Cremer, H; Sontag, KH; Wand, P | 1 |
Haacke, U; Sturm, G; Süwer, V; Wesemann, W; Wildenhahn, G | 1 |
Grossmann, W; Jurna, I | 1 |
Smialowska, M | 2 |
Costall, B; Naylor, RJ | 1 |
Przewlocki, R | 1 |
Camanni, F; Fassio, V; Massara, F; Molinatti, GM; Müller, EE | 1 |
Grossmann, A; Grossmann, W; Jurna, I | 1 |
Feuerstein, TJ; Jackisch, R; Koch, R; Lücking, CH; Lupp, A | 1 |
Kornhuber, J; Weller, M | 2 |
Bormann, J; Hübers, M; Kornhuber, J; Riederer, P; Rusche, K | 1 |
Hönack, D; Löscher, W | 1 |
Koch, R; Reiser, G | 1 |
Bormann, J | 1 |
Bormann, J; Hübers, M; Kornhuber, J; Retz, W; Riederer, P | 1 |
Chen, ML; Lo, SC; Tsai, GC; Tsai, MC | 1 |
Gupta, RC; Kadel, WL | 1 |
Dimpfel, W; Koch, R; Schatton, W; Spüler, M | 1 |
Ljungberg, T | 1 |
Koch, R; Schatton, W; Verspohl, EJ | 1 |
Enomoto, K; Maeno, T; Masuo, K | 1 |
Binmöller, FJ; Koch, R; Reiser, G | 1 |
Ambrozi, L; Danielczyk, W | 1 |
Buchgeher, A; Fleischhacker, WW; Schubert, H | 1 |
Ammon, HP; Youssif, N | 1 |
Milios, E; Mundinger, F | 1 |
Czuczwar, SJ; Meldrum, BS; Schwarz, M; Sontag, KH; Turski, L | 1 |
Maj, J | 1 |
Beale, R; Golombiowska-Nikitin, K; Osborne, NN; Sontag, KH | 1 |
Klee, MR | 1 |
Maj, J; Sontag, KH; Wesemann, W | 1 |
Balzereit, F; Clemens, R; Fischer, PA; Fünfgeld, EW; Haase, HJ; Schneider, E | 1 |
Rohde, H | 1 |
Osborne, NN; Schwarz, M; Sontag, KH; Wand, P; Wesemann, W | 1 |
Miltner, FO | 2 |
Grossmann, W; Schütz, W | 1 |
Fünfgeld, EW; Sturm, G; Wesemann, W | 1 |
Kramer, MJ; Tilley, JW | 1 |
Danysz, W; Dill, D; Gossel, M; Quack, G; Zajaczkowski, W | 1 |
Danysz, W; Quack, G; Rogoz, Z; Skuza, G | 1 |
Feuerstein, TJ | 1 |
Kornhuber, J; Riederer, P; Schoppmeyer, K; Weller, M | 1 |
Bijak, M; Misgeld, U; Rohrbacher, J | 1 |
Finiels-Marlier, F; Paul, SM; Weller, M | 1 |
Danysz, W; Moryl, E; Quack, G | 1 |
Danysz, W; Mobley, SL; Wenk, GL | 1 |
Danysz, W; Hesselink, M; Quack, G; Spanagel, R | 1 |
Ferger, D; Krieglstein, J | 1 |
Krishtal, OA; Panchenko, VA; Parsons, CG; Pinchenko, VO; Tsyndrenko, AY | 1 |
Aizenman, E; Blanpied, TA; Boeckman, FA; Johnson, JW | 1 |
Camicioli, R; Ganzini, L; Young, BK | 1 |
Danysz, W; Kornhuber, J; Parsons, CG; Quack, G; Schmidt, WJ | 1 |
Koshelev, S; Sobolevsky, A | 1 |
Albrecht-Goepfert, E; Elstner, EF; Schempp, H | 1 |
Hartmann, S; Parsons, CG; Spielmanns, P | 1 |
Khodorov, BI; Koshelev, SG; Sobolevsky, AI | 1 |
Karge, E; Kerst, S; Klinger, W; Lupp, A; Quack, G | 1 |
Balster, RL; Jones, HE; Nicholson, KL | 1 |
Breimer, DD; Danysz, W; De Boer, BG; Hesselink, MB | 1 |
Breimer, DD; Danysz, W; De Boer, AG; Hesselink, MB | 1 |
Breimer, DD; Danysz, W; De Boer, AG; Hesselink, MB; Smolders, H | 1 |
Budziszewska, B; Jaworska-Feil, L; Kajta, M; Lasoń, W | 1 |
Archer, T; Danysz, W; Fredriksson, A; Quack, G | 1 |
Havel, J; Pazourek, J; Polásková, P; Reichová, N | 1 |
Fauler, G; Leis, HJ; Windischhofer, W | 1 |
Escobar, MR; Fourie, J; Sitar, DS | 1 |
Grützner, L | 1 |
Balster, RL; Harvey, SA; Nicholson, KL; Wiley, JL | 1 |
Hermans, E; Maloteaux, JM; Peeters, M | 1 |
Block, F; Habermeyer, B | 1 |
Fujii, Y; Higashi, Y | 1 |
Fujii, Y; Higashi, Y; Matsumura, H; Nakamura, S | 1 |
Caumont, AS; Hermans, E; Octave, JN | 1 |
Blaha, CD; Call, SB; Escher, T; Mittleman, G | 1 |
Rogóz, Z; Skuza, G | 1 |
Howland, RH | 1 |
Fang, F; Han, L; Ming, M; Shuangjin, C | 1 |
Cao, J; Li, YP; Li, ZR; Tao, YJ | 1 |
Maeng, S; Zarate, CA | 1 |
Abdurasulova, IN; Gmiro, VE; Serdyuk, SE | 1 |
Egashira, N; Fujiwara, M; Harada, S; Iwasaki, K; Matsushita, M; Mishima, K; Nishimura, R; Oishi, R; Okuno, R | 1 |
Büttner, T; Csoti, I; Kassubek, J; Reichmann, H; Riederer, P; Schulz, JB; Wüllner, U | 1 |
Chen, SH; Yang, YH; Yeh, HH | 1 |
Greenway, LL; Kuppuswamy, PS; Lauterbach, EC | 1 |
Bourne, PE; Dunkel, M; Koerner, S; Murgueitio, MS; Preissner, R; von Eichborn, J | 1 |
Janka, Z; Kalman, J; Szakacs, R | 1 |
Chen, YC; Chen, YW; Hung, CH; Leung, YM; Shieh, JP; Wang, JJ | 1 |
Branigan, E; Dougherty, DA; Lester, HA; Limapichat, W; Yu, WY | 1 |
Chalimoniuk, M; Dąbrowska-Bouta, B; Strużyńska, L; Sulkowski, G | 1 |
Carta, M; Collu, M; Fidalgo, C; Gardoni, F; Morelli, M; Stancampiano, R; Tronci, E; Zianni, E | 1 |
Ene-Stroescu, V; Nguyen, T; Waiblinger, BE | 1 |
Sureda, FX; Valverde, E; Vázquez, S | 1 |
Leong, NJ; Mcintosh, MP; Prankerd, RJ; Shackleford, DM | 1 |
Chen, D; Miao, H; Wu, Y; Zhao, Y | 1 |
Aksinenko, AY; Aliev, G; Bachurin, SO; Barreto, GE; Boltneva, NP; Bovina, EV; Echeverria, V; Fisenko, VP; Gabrelyan, AV; Grigoriev, VV; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Neganova, ME; Redkozubova, OM; Shevtsov, PN; Shevtsova, EF; Sokolov, VB | 1 |
Ma, HM; Zafonte, RD | 1 |
Grieb, P; Rejdak, K | 1 |
Brenner, SR | 1 |
Płusa, T | 1 |
Aksinenko, AY; Bachurin, SO; Boltneva, NP; Bovina, EV; Dubova, LG; Epishina, TA; Fisenko, VP; Gabrelyan, AV; Goreva, TV; Grigoriev, VV; Kovaleva, NV; Lushchekina, SV; Makhaeva, GF; Pushkareva, EA; Richardson, RJ; Rudakova, EV; Shevtsov, PN; Shevtsova, EF; Zamoyski, VL | 1 |
Bukh, J; Fahnøe, U; Galli, A; Gammeltoft, KA; Gottwein, JM; Offersgaard, A; Ramirez, S; Zhou, Y | 1 |
Fouilhé Sam-Laï, N; Jouanjus, E; Lapeyre-Mestre, M; Revol, B | 1 |
Chaffkin, J; Josephs, IA; Katz, ER | 1 |
Kuhn, W; Müller, T; Riederer, P | 1 |
15 review(s) available for memantine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Pathophysiology and therapy of malignant neuroleptic syndrome].
Topics: Amantadine; Antipsychotic Agents; Dantrolene; Dopamine; Dopamine Agents; Drug Therapy, Combination; Glutamine; Humans; Memantine; Neuroleptic Malignant Syndrome; Neurologic Examination; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate | 1992 |
[Pharmacodynamics and pharmacokinetics of memantine].
Topics: Amantadine; Animals; Antidepressive Agents; Body Temperature; Catalepsy; Dopamine; Dyskinesia, Drug-Induced; Electrophysiology; gamma-Aminobutyric Acid; Guinea Pigs; Hemodynamics; Humans; Kinetics; Memantine; Mice; Motor Activity; Norepinephrine; Rabbits; Rats; Respiration; Stereotyped Behavior | 1983 |
Aminoadamantane derivatives.
Topics: Amantadine; Animals; Antiviral Agents; Humans; Memantine; Nervous System Diseases; Rimantadine | 1981 |
Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
Topics: Adamantane; Amantadine; Animals; Behavior, Animal; Dopamine; Electrophysiology; Hallucinogens; Humans; Memantine; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders | 1994 |
[New therapeutic possibilities with low-affinity NMDA receptor antagonists].
Topics: Aged; Alzheimer Disease; Amantadine; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Glutamine; Humans; Memantine; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Receptors, Phencyclidine | 1996 |
Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
Topics: Aging; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Cholinergic Antagonists; Delirium; Dementia; Depression; Dopamine Agonists; Electroconvulsive Therapy; Humans; Levodopa; Memantine; Monoamine Oxidase Inhibitors; Psychoses, Substance-Induced; Risk Factors; Serotonin Antagonists | 1997 |
Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents--preclinical studies.
Topics: Amantadine; Animals; Antiparkinson Agents; Excitatory Amino Acid Antagonists; Memantine; Parkinson Disease, Secondary; Receptors, N-Methyl-D-Aspartate | 1997 |
[Glutamate antagonists for treatment of neuropathic pain].
Topics: Amantadine; Animals; Disease Models, Animal; Excitatory Amino Acid Antagonists; Humans; Ketamine; Memantine; Neuralgia | 2003 |
Glutamate-modulating drugs & the treatment of mental disorders.
Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines | 2007 |
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects.
Topics: Amantadine; Depressive Disorder, Major; Dopamine Agents; Excitatory Amino Acid Antagonists; Humans; Ketamine; Memantine; Mood Disorders; Receptors, AMPA; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate | 2007 |
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
Topics: Amantadine; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Parkinson Disease; Piperidines; Selegiline | 2010 |
The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depression.
Topics: Amantadine; Antidepressive Agents; Depressive Disorder, Major; Glutamates; Hippocampus; Humans; Memantine; Receptors, N-Methyl-D-Aspartate; Severity of Illness Index; Synaptic Transmission | 2012 |
Amantadine and memantine: a comprehensive review for acquired brain injury.
Topics: Amantadine; Brain Injuries; Humans; Memantine; Neuronal Plasticity; Off-Label Use; Recovery of Function | 2020 |
[Anti-inflammatory effects of amantadine and memantine in SARS-CoV-2 infection].
Topics: Amantadine; Anti-Inflammatory Agents; COVID-19; Humans; Memantine; SARS-CoV-2 | 2021 |
5 trial(s) available for memantine and amantadine
Article | Year |
---|---|
[Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].
Topics: Adult; Aged; Amantadine; Clinical Trials as Topic; Female; Humans; Infusions, Parenteral; Male; Memantine; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1977 |
Treatment of impaired cerebral function in psychogeriatric patients with memantine--results of a phase II double-blind study.
Topics: Aged; Amantadine; Dementia; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Memantine; Neuropsychological Tests | 1988 |
Memantine in the treatment of senile dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Amantadine; Clinical Trials as Topic; Female; Humans; Male; Memantine; Random Allocation | 1986 |
[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study].
Topics: Administration, Oral; Aged; Amantadine; Clinical Trials as Topic; Female; Humans; Male; Memantine; Middle Aged; Movement Disorders; Parkinson Disease; Placebos; Substantia Nigra; Tremor | 1984 |
[Results of clinical trials of the antispasmodic agent memantine].
Topics: Aged; Amantadine; Brain Injuries; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Encephalomyelitis; Female; Humans; Male; Memantine; Middle Aged | 1982 |
109 other study(ies) available for memantine and amantadine
Article | Year |
---|---|
Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
Topics: Amantadine; Animals; Antiparkinson Agents; Mice; Motor Activity; Receptors, Dopamine; Structure-Activity Relationship | 1982 |
Quantitative analysis of the structural requirements for blockade of the N-methyl-D-aspartate receptor at the phencyclidine binding site.
Topics: Binding Sites; Excitatory Amino Acid Antagonists; Humans; Molecular Structure; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 1998 |
Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.
Topics: Amantadine; Biological Transport; Carrier Proteins; Dopamine Agents; Hippocampus; Humans; Immunohistochemistry; Memantine; Neurons; Neurotransmitter Agents; Organic Cation Transport Proteins; Organic Cation Transporter 2; Transcription, Genetic | 1998 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Synthesis and pharmacological evaluation of several ring-contracted amantadine analogs.
Topics: Amantadine; Animals; Antiviral Agents; Cells, Cultured; Dogs; Dopamine; Influenza A virus; Inhibitory Concentration 50; Receptors, N-Methyl-D-Aspartate | 2008 |
Synthesis and pharmacological evaluation of (2-oxaadamant-1-yl)amines.
Topics: Adamantane; Amines; Animals; Antiviral Agents; Cell Culture Techniques; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents | 2009 |
New oxapolycyclic cage amines with NMDA receptor antagonist and trypanocidal activities.
Topics: Amines; Animals; Antiparkinson Agents; Cells, Cultured; Humans; Memantine; Molecular Structure; Neurons; Parkinson Disease; Rats; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.
Topics: Amines; Antiviral Agents; DNA Viruses; Humans; Receptors, N-Methyl-D-Aspartate; Trypanocidal Agents; Trypanosoma brucei brucei | 2012 |
Cytoprotective effects of hydrogen sulfide-releasing
Topics: | 2014 |
Stereoselective synthesis and pharmacological evaluation of [4.3.3]propellan-8-amines as analogs of adamantanamines.
Topics: Amantadine; Animals; Antiviral Agents; Binding Sites; Cell Line; Chemistry Techniques, Synthetic; Crystallography, X-Ray; Dogs; Drug Evaluation, Preclinical; Humans; Influenza A virus; Madin Darby Canine Kidney Cells; Memantine; Phencyclidine; Receptors, N-Methyl-D-Aspartate; Static Electricity; Stereoisomerism | 2015 |
DABMA: A Derivative of ABMA with Improved Broad-Spectrum Inhibitory Activity of Toxins and Viruses.
Topics: | 2019 |
Open and rearranged norbornane derived polycyclic cage molecules as potential neuroprotective agents through attenuation of MPP
Topics: 1-Methyl-4-phenylpyridinium; Calcium; Cell Line, Tumor; Humans; Ion Transport; Molecular Docking Simulation; Neuroblastoma; Neuroprotective Agents; Norbornanes; Polycyclic Compounds; Receptors, N-Methyl-D-Aspartate; Spectrum Analysis; Structure-Activity Relationship | 2020 |
Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Caenorhabditis elegans; Disease Models, Animal; Memantine; Mice; Receptors, N-Methyl-D-Aspartate | 2022 |
GABA-ergic drugs block the locomotor stimulant effects of 1,3-dimethyl-5-aminoadamantane (D-145).
Topics: Amantadine; Aminooxyacetic Acid; Animals; Dextroamphetamine; gamma-Aminobutyric Acid; Memantine; Mice; Motor Activity; Time Factors | 1979 |
[Gaschromatographic and mass spectrometric studies on metabolites of adamantane amines excreted with urine (author's transl)].
Topics: Amantadine; Animals; Chemical Phenomena; Chemistry; Chromatography, Gas; Male; Mass Spectrometry; Memantine; Rats; Time Factors | 1977 |
Effects of 1,3-dimethyl-5-aminoadamantane hydrochloride (DMAA) on the stretch-induced reflex tension of flexor muscles and the excitability of the gamma-loop in decerebrate and spinal cats.
Topics: Amantadine; Animals; Cats; Decerebrate State; Female; Male; Memantine; Motor Neurons; Muscle Tonus; Neurons, Afferent; Reflex; Spinal Cord | 1977 |
[The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].
Topics: Amantadine; Animals; Blood Platelets; Brain; Depression, Chemical; Dopamine; Electric Stimulation; Humans; In Vitro Techniques; Memantine; Nerve Endings; Rats; Serotonin | 1977 |
[The effect of memantine (dimethylamino-adamantane) on membranes of sensory nerve fibres (author's transl)].
Topics: Action Potentials; Amantadine; Animals; In Vitro Techniques; Memantine; Membrane Potentials; Nerve Fibers; Rats; Time Factors | 1977 |
Pharmacological evidence for the involvement of GABA-ergic system in the locomotor stimulation produced in mice by 1,3-dimethyl-5-aminoadamantane (D-145).
Topics: Amantadine; Aminooxyacetic Acid; Animals; Dextroamphetamine; Drug Interactions; gamma-Aminobutyric Acid; Male; Memantine; Methyltyrosines; Mice; Motor Activity; Phenoxybenzamine; Reserpine | 1978 |
Histofluorescence studies on the effect of 1,3-dimethyl-5-adamantanamine (D-145) on serotonin neurons in midbrain raphe nuclei.
Topics: Amantadine; Animals; Catecholamines; Dopamine; Fluorescence; Histocytochemistry; Male; Memantine; Mesencephalon; Neurons; Rats; Receptors, Drug; Serotonin; Time Factors | 1976 |
The influence of 1,3-dimethyl-5-adamantanamine (D-145) on catecholaminergic neurons of the rat brain, Histofluorescence studies.
Topics: Amantadine; Animals; Behavior, Animal; Brain; Catecholamines; Depression, Chemical; Fluorescence; Histocytochemistry; Male; Memantine; Methyltyrosines; Neurons; Rats; Spiperone; Time Factors | 1976 |
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
Topics: Amantadine; Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Humans; Hypothalamus; Limbic System; Male; Memantine; Methyltyrosines; Motor Activity; Parkinson Disease; Rats; Reserpine; Reticular Formation; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra | 1975 |
The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (DMAA) on ponto-geniculo-occipital (PGO) waves in cats.
Topics: Amantadine; Animals; Apomorphine; Benserazide; Cats; Dopamine; Electroencephalography; Geniculate Bodies; Memantine; Occipital Lobe; Serotonin | 1975 |
Effect of five dopaminergic drugs on plasma growth hormone levels in acromegalic subjects.
Topics: Acromegaly; Adult; Aged; Amantadine; Bromocriptine; Ergolines; Female; Growth Hormone; Humans; Levodopa; Male; Memantine; Middle Aged; Piperazines; Piribedil | 1975 |
The effect of dimethylaminoadamantane on neuronal membranes.
Topics: Amantadine; Animals; Calcium; Cell Membrane; Cell Membrane Permeability; Chlorides; Electric Stimulation; Evoked Potentials; In Vitro Techniques; Memantine; Neurons; Osmolar Concentration; Potassium; Rats; Sensory Receptor Cells; Sodium; Spinal Nerve Roots | 1976 |
Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in the rabbit caudate nucleus in vitro.
Topics: Acetylcholine; Amantadine; Animals; Caudate Nucleus; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Female; Glutamates; Glutamic Acid; In Vitro Techniques; Magnesium; Male; Memantine; N-Methylaspartate; Rabbits; Receptors, N-Methyl-D-Aspartate; Tetrodotoxin; Tritium | 1992 |
Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.
Topics: Adamantane; Amantadine; Binding Sites; Brain; Dizocilpine Maleate; Humans; Ion Channel Gating; Ion Channels; Kinetics; Memantine; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Tritium | 1991 |
High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats.
Topics: Amantadine; Amygdala; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Female; Kindling, Neurologic; Memantine; Rats; Rats, Inbred Strains; Seizures | 1990 |
Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line.
Topics: Amantadine; Animals; Calcium; Cyclic GMP; Cytosol; Glioma; Memantine; Nervous System Neoplasms; Neuroblastoma; Neurons; Rats; Serotonin; Serotonin Antagonists; Tumor Cells, Cultured | 1989 |
Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels.
Topics: Amantadine; Animals; Cells, Cultured; Embryo, Mammalian; Female; Memantine; Membranes; Mice; Neuroglia; Neurons; Pregnancy; Receptors, N-Methyl-D-Aspartate; Receptors, Neurotransmitter; Spinal Cord | 1989 |
Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.
Topics: Adult; Aged; Amantadine; Binding, Competitive; Cerebral Cortex; Dibenzocycloheptenes; Dizocilpine Maleate; Female; Humans; In Vitro Techniques; Male; Memantine; Middle Aged | 1989 |
Effects of memantine on the twitch tension of mouse diaphragm.
Topics: Amantadine; Animals; Diaphragm; Electric Stimulation; Evoked Potentials; In Vitro Techniques; Memantine; Mice; Mice, Inbred ICR; Muscle Contraction; Phrenic Nerve; Respiratory Muscles | 1989 |
Prevention and antagonism of acute carbofuran intoxication by memantine and atropine.
Topics: Acetylcholinesterase; Amantadine; Animals; Atropine; Carbofuran; Carboxylesterase; Carboxylic Ester Hydrolases; Chemical Phenomena; Chemistry; Cholinesterase Inhibitors; Drug Antagonism; Drug Synergism; Insecticides; Male; Memantine; Rats; Rats, Inbred Strains | 1989 |
Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Animals; Benzazepines; Brain; Corpus Striatum; Electroencephalography; Ergolines; Evoked Potentials; Frontal Lobe; Haloperidol; Hippocampus; Male; Memantine; Quinpirole; Rats; Rats, Inbred F344; Receptors, Dopamine; Reticular Formation; Synaptic Transmission; Telemetry | 1987 |
Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
Topics: Amantadine; Animals; Antipsychotic Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Interactions; Male; Memantine; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1986 |
Interaction of memantine with cholecystokinin receptors in mouse brain.
Topics: Amantadine; Animals; Brain; Cell Membrane; In Vitro Techniques; Iodine Radioisotopes; Male; Memantine; Mice; Receptors, Cholecystokinin | 1988 |
Effects of memantine on the frog neuromuscular junction.
Topics: Acetylcholine; Amantadine; Animals; Carbachol; In Vitro Techniques; Memantine; Neuromuscular Junction; Rana pipiens; Ranidae; Synaptic Transmission | 1986 |
Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line.
Topics: Amantadine; Animals; Calcium; Cell Line; Glioma; Hybrid Cells; Memantine; Membrane Potentials; Neuroblastoma; Neurons; Serotonin; Serotonin Antagonists; Sodium; Tetrodotoxin | 1988 |
Potentiation of the locomotor activity of memantine by aminophylline.
Topics: Amantadine; Aminophylline; Animals; Circadian Rhythm; Drug Synergism; Female; Kinetics; Male; Memantine; Mice; Motor Activity | 1986 |
[Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
Topics: Adolescent; Adult; Aged; Amantadine; Athetosis; Basal Ganglia Diseases; Cerebral Palsy; Child; Chorea; Combined Modality Therapy; Dystonia Musculorum Deformans; Female; Humans; Male; Memantine; Middle Aged; Muscle Spasticity; Stereotaxic Techniques | 1985 |
Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio.
Topics: Amantadine; Animals; Anticonvulsants; Electroshock; Male; Memantine; Mice; Papio; Photic Stimulation; Species Specificity | 1986 |
[Effect of memantine on central neurotransmitter systems. Review of the results].
Topics: Acetylcholine; Amantadine; Animals; Blood Pressure; Catalepsy; Central Nervous System; gamma-Aminobutyric Acid; Humans; Memantine; Motor Activity; Neurotransmitter Agents; Rats; Receptors, Dopamine; Receptors, Serotonin; Rotation; Stereotyped Behavior; Temperature | 1982 |
The effect of memantine on various neurobiological processes.
Topics: Amantadine; Animals; Autoradiography; Binding, Competitive; Biogenic Amines; Cells, Cultured; Immunochemistry; Male; Memantine; Neurotransmitter Agents; Potassium; Rats; Rats, Inbred Strains; Retina; Serotonin; Spiperone; Substance P | 1982 |
[Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica].
Topics: Action Potentials; Amantadine; Animals; Aplysia; Electric Stimulation; Memantine; Membrane Potentials; Membranes; Neurons; Synapses; Synaptic Transmission | 1982 |
[Antispasm therapy: memantine. Symposium 29-30 October 1982 at Frankfurt am Main].
Topics: Amantadine; Humans; Memantine | 1983 |
[The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].
Topics: Amantadine; Animals; Biogenic Amines; Cats; Corpus Striatum; Dopamine; Memantine; Motor Activity; Motor Neurons; Norepinephrine; Rats; Rats, Inbred Strains; Receptors, Drug; Serotonin; Spinal Cord | 1982 |
Distribution of memantine in brain, liver, and blood of the rat.
Topics: Amantadine; Animals; Brain; Chromatography, Gas; Liver; Male; Memantine; Rats; Rats, Inbred Strains; Time Factors | 1982 |
[Valve of symptomatic therapy with memantine in cerebral coma. I. Correlation with coma stages and EEG spectral patterns].
Topics: Adolescent; Adult; Amantadine; Coma; Electroencephalography; Female; Humans; Male; Memantine | 1982 |
[Valve of symptomatic therapy with memantine in cerebral coma. II. Development of stretch synergisms in coma with brain stem symptoms].
Topics: Amantadine; Brain Stem; Coma; Electromyography; Female; Humans; Male; Memantine; Movement; Posture | 1982 |
[Memantine and neurogenic bladder disorders within the bounds of spastic conditions].
Topics: Adult; Aged; Amantadine; Electromyography; Female; Humans; Male; Memantine; Middle Aged; Muscle Spasticity; Urinary Bladder, Neurogenic; Urination | 1982 |
Distribution of metabolism of the potential anti-parkinson drug memantine in the human.
Topics: Aged; Amantadine; Antiparkinson Agents; Brain Chemistry; Female; Humans; Memantine; Parkinson Disease; Tissue Distribution | 1980 |
Are NMDA antagonistic properties relevant for antiparkinsonian-like activity in rats?--case of amantadine and memantine.
Topics: Amantadine; Animals; Catalepsy; Dizocilpine Maleate; Locomotion; Male; Memantine; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra | 1994 |
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 1994 |
[Ketamine inhibits n-methyl-d-aspartate (NMDA) receptor mediated acetylcholine release from rabbit caudate nucleus slices].
Topics: Acetylcholine; Action Potentials; Amantadine; Animals; Caudate Nucleus; Choline; Dizocilpine Maleate; In Vitro Techniques; Ketamine; Memantine; Rabbits; Receptors, N-Methyl-D-Aspartate; Valine | 1994 |
Suppression by memantine and amantadine of synaptic excitation intrastriatally evoked in rat neostriatal slices.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Amantadine; Animals; Antiparkinson Agents; In Vitro Techniques; Memantine; Neostriatum; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission | 1994 |
NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine.
Topics: Amantadine; Animals; Cell Survival; Cells, Cultured; Cerebellum; Cerebral Cortex; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Memantine; Mesencephalon; Neurons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1993 |
Potential antidepressive properties of amantadine, memantine and bifemelane.
Topics: Amantadine; Analysis of Variance; Animals; Antidepressive Agents; Benzhydryl Compounds; Body Temperature; Depression; Hypothermia; Male; Memantine; Mice; Motor Activity; Rats; Rats, Wistar | 1993 |
MK-801, memantine and amantadine show neuroprotective activity in the nucleus basalis magnocellularis.
Topics: Amantadine; Animals; Basal Ganglia; Cerebral Cortex; Choline O-Acetyltransferase; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Memantine; N-Methylaspartate; Nervous System Diseases; Neuroprotective Agents; Rats; Receptors, N-Methyl-D-Aspartate | 1995 |
Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amantadine; Animals; Antiparkinson Agents; Brain; Dopamine; Dopamine Agents; Excitatory Amino Acid Antagonists; Homovanillic Acid; Male; Memantine; Microdialysis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1995 |
Determination of intracellular Ca2+ concentration can be a useful tool to predict neuronal damage and neuroprotective properties of drugs.
Topics: Amantadine; Analysis of Variance; Animals; Biomarkers; Calcium; Cell Hypoxia; Cell Survival; Cells, Cultured; Chickens; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Kinetics; Memantine; N-Methylaspartate; Neurons; Neuroprotective Agents; Quinoxalines; Sodium Cyanide; Telencephalon; Time Factors | 1996 |
Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine.
Topics: Amantadine; Animals; Dose-Response Relationship, Drug; Hippocampus; Ketamine; Memantine; Membrane Potentials; N-Methylaspartate; Patch-Clamp Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1996 |
Trapping channel block of NMDA-activated responses by amantadine and memantine.
Topics: Amantadine; Animals; Antiparkinson Agents; Cells, Cultured; CHO Cells; Cricetinae; DNA; Excitatory Amino Acid Agonists; Ion Channels; Kinetics; Memantine; Membrane Potentials; Models, Neurological; N-Methylaspartate; Patch-Clamp Techniques; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission | 1997 |
Two blocking sites of amino-adamantane derivatives in open N-methyl-D-aspartate channels.
Topics: Adamantane; Amantadine; Animals; Binding Sites; Cell Membrane; Cell Separation; Hippocampus; In Vitro Techniques; Kinetics; Memantine; Membrane Potentials; Models, Chemical; Models, Molecular; Patch-Clamp Techniques; Pyramidal Cells; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 1998 |
Modulation of the production of reactive oxygen species by pre-activated neutrophils by aminoadamantane derivatives.
Topics: alpha 1-Antitrypsin; Amantadine; Amino Acids; Amino Acids, Cyclic; Animals; Antioxidants; Ethylenes; Lipid Peroxidation; Memantine; Neutrophil Activation; Neutrophils; Oxidation-Reduction; Peroxidase; Piperazines; Reactive Oxygen Species; Swine | 1998 |
Budipine is a low affinity, N-methyl-D-aspartate receptor antagonist: patch clamp studies in cultured striatal, hippocampal, cortical and superior colliculus neurones.
Topics: Amantadine; Animals; Antiparkinson Agents; Brain; Cells, Cultured; Cerebral Cortex; Embryo, Mammalian; Hippocampus; Memantine; Neostriatum; Neurons; Patch-Clamp Techniques; Piperidines; Rats; Receptors, N-Methyl-D-Aspartate; Superior Colliculi | 1998 |
Interaction of memantine and amantadine with agonist-unbound NMDA-receptor channels in acutely isolated rat hippocampal neurons.
Topics: 2-Amino-5-phosphonovalerate; Amantadine; Animals; Aspartic Acid; Evoked Potentials; Excitatory Amino Acid Antagonists; Glycine; Hippocampus; In Vitro Techniques; Memantine; Membrane Potentials; Neurons; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1998 |
Investigation on possible antioxidative properties of the NMDA-receptor antagonists ketamine, memantine, and amantadine in comparison to nicanartine in vitro.
Topics: 7-Alkoxycoumarin O-Dealkylase; Amantadine; Animals; Antioxidants; Antiparkinson Agents; Cytochrome P-450 CYP1A1; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Hydrogen Peroxide; Ketamine; Lipid Peroxidation; Male; Memantine; Microsomes, Liver; Pyridines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Thiobarbituric Acid Reactive Substances | 1998 |
Evaluation of the reinforcing and discriminative stimulus properties of the low-affinity N-methyl-D-aspartate channel blocker memantine.
Topics: Amantadine; Animals; Discrimination, Psychological; Dopamine Agents; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Female; Macaca mulatta; Male; Memantine; Phencyclidine; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement, Psychology; Self Administration | 1998 |
Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study.
Topics: Amantadine; Animals; Biological Transport; Brain Chemistry; Dopamine Agents; Excitatory Amino Acid Antagonists; Extracellular Space; Male; Memantine; Microdialysis; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 1999 |
Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists.
Topics: Amantadine; Animals; Brain; Caudate Nucleus; Dentate Gyrus; Dizocilpine Maleate; Entorhinal Cortex; Frontal Lobe; Hippocampus; Infusions, Parenteral; Kinetics; Male; Memantine; Nucleus Accumbens; Organ Specificity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Muscarinic; Receptors, N-Methyl-D-Aspartate; Salicylamides; Time Factors | 1999 |
Modifications of the behavioral profile of non-competitive NMDA receptor antagonists, memantine, amantadine and (+)MK-801 after chronic administration.
Topics: Amantadine; Animals; Ataxia; Avoidance Learning; Behavior, Animal; Catalepsy; Dizocilpine Maleate; Drug Implants; Excitatory Amino Acid Antagonists; Male; Memantine; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Sympathectomy, Chemical; Sympathomimetics; Time Factors | 1999 |
Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism.
Topics: Amantadine; Animals; Antidepressive Agents; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Cocaine; Corticosterone; Cyclic AMP; Cyclic GMP; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Gene Expression Regulation; Imipramine; Lithium Chloride; Memantine; Mifepristone; Protein Kinase Inhibitors; Pyrrolidinones; Receptors, Glucocorticoid; Receptors, Steroid; Sulfonamides; Tamoxifen; Thionucleotides; Time Factors; Transcription, Genetic; Type C Phospholipases | 2000 |
Co-administration of memantine and amantadine with sub/suprathreshold doses of L-Dopa restores motor behaviour of MPTP-treated mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Levodopa; Male; Memantine; Mice; Mice, Inbred C57BL; Motor Activity; Parkinsonian Disorders; Recovery of Function | 2001 |
Electrophoretic behavior of adamantane derivatives possessing antiviral activity and their determination by capillary zone electrophoresis with indirect detection.
Topics: alpha-Cyclodextrins; Amantadine; Antiviral Agents; beta-Cyclodextrins; Cyclodextrins; Electric Conductivity; Electrophoresis, Capillary; Memantine; Rimantadine | 2002 |
Quantitative analysis of memantine in human plasma by gas chromatography/negative ion chemical ionization/mass spectrometry.
Topics: Amantadine; Antiparkinson Agents; Biological Availability; Blood Preservation; Calibration; Cryopreservation; Gas Chromatography-Mass Spectrometry; Humans; Memantine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Spectrometry, Mass, Secondary Ion | 2002 |
NMDA receptor antagonists to characterize rat renal organic cation transporter function.
Topics: Amantadine; Animals; Cyclopentanes; Drug Interactions; Energy Metabolism; Excitatory Amino Acid Antagonists; In Vitro Techniques; Kidney; Kidney Tubules; Kinetics; Male; Memantine; Organic Cation Transport Proteins; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2002 |
[Case report. Dementia with apathy].
Topics: Administration, Oral; Aged; Alzheimer Disease; Amantadine; Bronchopneumonia; Confusion; Dehydration; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Memantine; Patient Admission | 2002 |
Affinity and specificity of N-methyl- D-aspartate channel blockers affect their ability to disrupt prepulse inhibition of acoustic startle in rats.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Alanine; Amantadine; Animals; Binding Sites; Desipramine; Dextromethorphan; Dextrorphan; Dizocilpine Maleate; Dopamine Agents; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ibogaine; Loudness Perception; Male; Memantine; Muscarinic Antagonists; Neural Inhibition; Orphenadrine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Selective Serotonin Reuptake Inhibitors | 2003 |
Distinct effects of amantadine and memantine on dopaminergic transmission in the rat striatum.
Topics: Amantadine; Animals; Benzazepines; Carbachol; Dopamine; Dopamine Agents; Dopamine Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Kinetics; Male; Memantine; Membranes; Muscarinic Agonists; Neostriatum; Rats; Rats, Wistar; Spiperone; Synaptic Transmission; Synaptosomes | 2003 |
Simultaneous determination of the binding of amantadine and its analogues to synthetic melanin by liquid chromatography after precolumn derivatization with dansyl chloride.
Topics: Amantadine; Chromatography, Liquid; Dansyl Compounds; Melanins; Memantine; Reproducibility of Results; Rimantadine | 2005 |
Simultaneous liquid chromatographic assay of amantadine and its four related compounds in phosphate-buffered saline using 4-fluoro-7-nitro-2,1,3-benzoxadiazole as a fluorescent derivatization reagent.
Topics: 4-Chloro-7-nitrobenzofurazan; Amantadine; Binding, Competitive; Calibration; Chromatography, High Pressure Liquid; Fluorescent Dyes; Humans; Memantine; Phosphates; Reproducibility of Results; Rimantadine; Sodium Chloride | 2006 |
Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells.
Topics: 5' Untranslated Regions; Amantadine; Animals; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Dopamine Agents; Glial Cell Line-Derived Neurotrophic Factor; Glioma; Immunoassay; Memantine; Molecular Sequence Data; Promoter Regions, Genetic; Rats; Receptors, N-Methyl-D-Aspartate; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazolium Salts; Thiazoles | 2006 |
Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice.
Topics: Alcohol Drinking; Amantadine; Animals; Behavior, Animal; Central Nervous System Depressants; Conditioning, Operant; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Ethanol; Excitatory Amino Acid Antagonists; Locomotion; Male; Memantine; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Reinforcement Schedule; Self Administration | 2006 |
The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats.
Topics: Adrenergic alpha-Antagonists; Amantadine; Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Ethylenediamines; Indoles; Male; Memantine; Motor Activity; Piperazines; Prazosin; Progesterone; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Spiro Compounds; Sulpiride; Swimming | 2006 |
New method for high-performance liquid chromatographic determination of amantadine and its analogues in rat plasma.
Topics: Amantadine; Animals; Antiviral Agents; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Feasibility Studies; Male; Memantine; Molecular Structure; Rats; Rats, Sprague-Dawley; Rimantadine; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2007 |
[Synthesis and neuroprotective activity in cell culture of aminoadamantane analogues].
Topics: Amantadine; Cell Death; Cell Line, Tumor; Glutamic Acid; Humans; L-Lactate Dehydrogenase; Memantine; Neuroblastoma; Neuroprotective Agents | 2007 |
Comparative study of preventive and therapeutic effects of IEM-1966 and memantine in rats with experimental allergic encephalomyelitis.
Topics: Amantadine; Animals; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Memantine; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2007 |
Effects of glutamate-related drugs on marble-burying behavior in mice: implications for obsessive-compulsive disorder.
Topics: Acoustic Stimulation; Amantadine; Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Memantine; Mice; Mice, Inbred ICR; Motor Activity; Obsessive-Compulsive Disorder; Quinoxalines; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Riluzole | 2008 |
Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application.
Topics: Acetonitriles; Alzheimer Disease; Amantadine; Antiparkinson Agents; Chemical Fractionation; Chromatography, Micellar Electrokinetic Capillary; Fluoresceins; Humans; Hydrogen-Ion Concentration; Linear Models; Memantine; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence; Succinimides | 2010 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinical Trials as Topic; Dibenzothiazepines; Donepezil; Dopamine Agents; Excitatory Amino Acid Antagonists; Female; Frontotemporal Dementia; Humans; Hypnotics and Sedatives; Indans; Lorazepam; Memantine; Middle Aged; Nootropic Agents; Piperazines; Piperidines; Pramipexole; Quetiapine Fumarate; Quinolones; Selective Serotonin Reuptake Inhibitors | 2010 |
PROMISCUOUS: a database for network-based drug-repositioning.
Topics: Amantadine; Antidepressive Agents, Tricyclic; Databases, Factual; Dopamine Agents; Drug Repositioning; Memantine; Mianserin; Mirtazapine; Pharmaceutical Preparations; Protein Interaction Mapping; Proteins | 2011 |
Cutaneous analgesia after subcutaneous injection of memantine and amantadine and their systemic toxicity in rats.
Topics: Amantadine; Analgesia; Analgesics, Non-Narcotic; Anesthetics, Local; Animals; Apnea; Behavior, Animal; Blood Pressure; Heart Rate; Injections, Subcutaneous; Male; Memantine; Rats; Rats, Sprague-Dawley; Seizures; Skin | 2012 |
Key binding interactions for memantine in the NMDA receptor.
Topics: Amantadine; Animals; Binding Sites; Excitatory Amino Acid Antagonists; Inhibitory Concentration 50; Memantine; Patch-Clamp Techniques; Protein Structure, Tertiary; Rats; Receptors, N-Methyl-D-Aspartate; Xenopus laevis | 2013 |
Effects of antagonists of glutamate receptors on pro-inflammatory cytokines in the brain cortex of rats subjected to experimental autoimmune encephalomyelitis.
Topics: Amantadine; Animals; Cerebral Cortex; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Excitatory Amino Acid Antagonists; Female; Guinea Pigs; Inflammation Mediators; Memantine; Rats; Rats, Inbred Lew; Receptors, N-Methyl-D-Aspartate; Treatment Outcome | 2013 |
Effect of memantine on L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's disease.
Topics: Amantadine; Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesias; Excitatory Amino Acid Antagonists; Levodopa; Male; Memantine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley | 2014 |
Successful treatment of catatonia in a young man with schizophrenia and progressive diffuse cerebral atrophy.
Topics: Adolescent; Amantadine; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Atrophy; Catatonia; Cerebral Cortex; Clozapine; Drug Therapy, Combination; Humans; Magnetic Resonance Imaging; Male; Memantine; Schizophrenia; Valproic Acid | 2014 |
Novel benzopolycyclic amines with NMDA receptor antagonist activity.
Topics: Amantadine; Amines; Memantine; Neuroprotective Agents; Protein Binding; Receptors, N-Methyl-D-Aspartate | 2014 |
The effect of intravenous sulfobutylether7 -β-cyclodextrin on the pharmacokinetics of a series of adamantane-containing compounds.
Topics: Amantadine; Animals; beta-Cyclodextrins; Drug Interactions; Erythrocytes; Injections, Intravenous; Male; Memantine; Models, Biological; Protein Binding; Rats, Sprague-Dawley; Rimantadine | 2015 |
Dispersive micro solid phase extraction of amantadine, rimantadine and memantine in chicken muscle with magnetic cation exchange polymer.
Topics: Adsorption; Amantadine; Animals; Antiviral Agents; Cations; Chickens; Chromatography, High Pressure Liquid; Dopamine Agents; Food Contamination; Limit of Detection; Magnets; Mass Spectrometry; Memantine; Muscles; Polymers; Poultry; Rimantadine; Solid Phase Extraction | 2017 |
Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment.
Topics: Alzheimer Disease; Amantadine; Carbazoles; Carboxylesterase; Cholinesterase Inhibitors; Drug Design; Erythrocytes; Humans; Memantine; Microtubules; Molecular Docking Simulation; Protein Binding; Receptors, N-Methyl-D-Aspartate | 2017 |
Adamantanes might be protective from COVID-19 in patients with neurological diseases: multiple sclerosis, parkinsonism and cognitive impairment.
Topics: Adamantane; Adult; Aged; Aged, 80 and over; Amantadine; Asymptomatic Infections; Betacoronavirus; Cognitive Dysfunction; Coronavirus Infections; COVID-19; Dopamine Agents; Female; Humans; Male; Memantine; Middle Aged; Multiple Sclerosis; Pandemics; Parkinson Disease; Pneumonia, Viral; Protective Factors; SARS-CoV-2; Severity of Illness Index | 2020 |
The potential of memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
Topics: Adamantane; Amantadine; COVID-19; Humans; Lysosomes; Memantine; Respiratory Distress Syndrome; Respiratory Insufficiency; SARS-CoV-2; Virus Replication | 2020 |
Conjugation of Aminoadamantane and γ-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands.
Topics: Acetylcholinesterase; Amantadine; Animals; Butyrylcholinesterase; Carbolines; Carboxylesterase; Catalytic Domain; Cell Line; Cholinesterase Inhibitors; Horses; Humans; Kinetics; Ligands; Memantine; Mitochondrial Transmembrane Permeability-Driven Necrosis; Molecular Docking Simulation; Propidium; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship; Swine; Tubulin; Tubulin Modulators | 2021 |
Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro.
Topics: A549 Cells; Adenosine Monophosphate; Alanine; Amantadine; Animals; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; COVID-19 Drug Treatment; Denmark; Drug Repositioning; Humans; Ion Channels; Memantine; Rimantadine; SARS-CoV-2; Vero Cells | 2021 |
Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database.
Topics: Amantadine; Analgesics; Bayes Theorem; Dextromethorphan; Humans; Ketamine; Memantine; Pharmacovigilance; Receptors, N-Methyl-D-Aspartate; Substance-Related Disorders; World Health Organization | 2022 |
Safe Use of Memantine in a Pediatric Patient With Catatonia.
Topics: Adolescent; Amantadine; Benzodiazepines; Catatonia; Electroconvulsive Therapy; Humans; Memantine | 2022 |
Aminoadamantanes: from treatment of Parkinson's and Alzheimer's disease to symptom amelioration of long COVID-19 syndrome?
Topics: Alzheimer Disease; Amantadine; COVID-19; Humans; Memantine; Parkinson Disease; Post-Acute COVID-19 Syndrome | 2023 |